Search
for
Sort by
Research 121–150 of 846
- USE OF SPIRONOLACTONE IN COMBINATION WITH AN ORAL CONTRACEPTIVE IN TREATMENT OF HIRSUTISM
- Pharmakokinetik und Biokonversion von Dehydroepiandrosteron nach Dexamethason-Vorbehandlung bei Frauen mit dem Syndrom der polyzystischen Ovarien
- Nonclassic adrenal hyperplasia
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor
- Polycystic ovary syndrome: diagnosis and management of related infertility
- Hormones
- Syndrome des ovaires polykystiques : Point de vue contemporain
- Exploring phytoandrogens: A review of their potential in health and medicine
- A review on PCOS: Its causes, symptoms, pathogenesis and management
- The Role of Hormonal Imbalances in Amenorrhea
- Penis Endocrinology
- 196 The endocannabinoid tone regulates human sebocyte biology
- 194 An underlying mechanism of hair loss in acrodermatitis enteropathica
- 192 MicroRNAs and their regulatory interactions in the human hair follicle
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- The North American Menopause Society Recommendations for Clinical Care of Midlife Women
- Endocrinology of Transgender Medicine
- Hormone therapy for transgender patients
- Adult polycystic ovary syndrome begins in childhood
- Hormonal contraceptives: pharmacology tailored to women's health
- Health and fertility in World Health Organization group 2 anovulatory women
- <i>Polycystic Ovary Syndrome in Adolescence</i>
- Review of Hair Follicle Dermal Papilla cells as <i>in vitro</i> screening model for hair growth
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Semen Parameters Among Transgender Women With a History of Hormonal Treatment
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia